HUP0103781A3 - Pharmaceutical compositions comprising atypical antiphsychotic agent in combination with acetylcholinesterase inhibitor for improving cognition - Google Patents

Pharmaceutical compositions comprising atypical antiphsychotic agent in combination with acetylcholinesterase inhibitor for improving cognition

Info

Publication number: HUP0103781A3
Authority: HU; Hungary
Prior art keywords: antiphsychotic; atypical; agent; combination; pharmaceutical compositions
Prior art date: 1998-10-16

Application number

HU0103781A

Other languages

Hungarian (hu)

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-12

Publication date

2003-09-29

1999-10-12 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-03-28 Publication of HUP0103781A2 publication Critical patent/HUP0103781A2/en

2003-09-29 Publication of HUP0103781A3 publication Critical patent/HUP0103781A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

HU0103781A 1998-10-16 1999-10-12 Pharmaceutical compositions comprising atypical antiphsychotic agent in combination with acetylcholinesterase inhibitor for improving cognition HUP0103781A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203454		1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en)	1998-10-16	1999-10-12	Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (2)

Publication Number	Publication Date
HUP0103781A2 HUP0103781A2 (en)	2002-03-28
HUP0103781A3 true HUP0103781A3 (en)	2003-09-29

Family

ID=8234219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0103781A HUP0103781A3 (en)	1998-10-16	1999-10-12	Pharmaceutical compositions comprising atypical antiphsychotic agent in combination with acetylcholinesterase inhibitor for improving cognition

Country Status (20)

Country	Link
EP (1)	EP1121131A2 (en)
JP (1)	JP2002527469A (en)
KR (1)	KR20010072878A (en)
CN (1)	CN1367697A (en)
AU (1)	AU6472799A (en)
BG (1)	BG105302A (en)
BR (1)	BR9914419A (en)
CA (1)	CA2345767A1 (en)
EE (1)	EE200100136A (en)
HK (1)	HK1039745A1 (en)
HR (1)	HRP20010262A2 (en)
HU (1)	HUP0103781A3 (en)
ID (1)	ID28441A (en)
IL (1)	IL142588A0 (en)
NO (1)	NO20011403L (en)
PL (1)	PL348107A1 (en)
SK (1)	SK4592001A3 (en)
TR (1)	TR200101082T2 (en)
WO (1)	WO2000023057A2 (en)
ZA (1)	ZA200103081B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006201188B2 (en) *	2001-02-05	2007-11-15	Novartis Ag	New use of iloperidone
GB0102841D0 (en) *	2001-02-05	2001-03-21	Novartis Ag	Organic compounds
DE60238780D1 (en) *	2001-10-30	2011-02-10	Novartis Ag	DEPOT FORMULATIONS OF ILOPERIDONE AND A STAR-TERM POLYMER
GB0216416D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
US20040192754A1 (en) *	2003-03-24	2004-09-30	Shapira Nathan Andrew	Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) *	2003-04-01	2005-01-16	Novartis Ag	Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2005065645A2 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Donepezil formulations
AU2004325725A1 (en) *	2004-12-10	2006-06-22	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
WO2008055945A1 (en)	2006-11-09	2008-05-15	Probiodrug Ag	3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (en)	2006-11-30	2012-05-15	Probiodrug Ag	NEW INHIBITORS OF GLUTAMINYL CYCLASE
EA200901140A1 (en)	2007-03-01	2010-04-30	Пробиодруг Аг	NEW USE OF GLUTAMINYL CYCLLASE INHIBITORS
JP5667440B2 (en)	2007-04-18	2015-02-12	プロビオドルグエージー	Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (en) *	2007-07-16	2009-02-25	World Trade Imp Export Wtie Ag	Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a reversible inhibiting agent of the cholinesterase enzyme prescribed for the control and treatment of psychotic disorders and dementias.
CA2789014C (en)	2010-02-09	2019-01-15	Michela Gallagher	Methods and compositions for improving cognitive function
US9181233B2 (en)	2010-03-03	2015-11-10	Probiodrug Ag	Inhibitors of glutaminyl cyclase
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
JP5945532B2 (en)	2010-04-21	2016-07-05	プロビオドルグエージー	Benzimidazole derivatives as inhibitors of glutaminyl cyclase
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
EP2968237A4 (en)	2013-03-15	2016-08-31	Univ Johns Hopkins	METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
ES2881081T3 (en)	2013-03-15	2021-11-26	Agenebio Inc	Procedures and compositions to improve cognitive function
CA2986598C (en)	2015-05-22	2023-09-26	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
PL3461819T3 (en)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
WO1992020327A1 (en) *	1991-05-14	1992-11-26	Ernir Snorrason	Treatment of fatigue syndrome with cholinesterase inhibitors
AU8778498A (en) *	1997-08-11	1999-03-01	University Of South Florida Research Foundation, Inc.	Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
CA2601132C (en) *	1998-04-14	2011-11-08	The General Hospital Corporation	Use of n-methylglycine and pharmaceutical compositions comprising n-methylglycine for treating neuropsychiatric disorders

1999
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/en unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/en not_active Withdrawn
- 1999-10-12 PL PL99348107A patent/PL348107A1/en unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/en unknown
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/en not_active Application Discontinuation
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/en not_active Withdrawn
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/en unknown
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 IL IL14258899A patent/IL142588A0/en unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/en unknown
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/en not_active IP Right Cessation
- 1999-10-12 ID IDW20010828A patent/ID28441A/en unknown
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/en unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/en active Pending
2001
- 2001-03-01 BG BG105302A patent/BG105302A/en unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/en not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown

Also Published As

Publication number	Publication date
WO2000023057A3 (en)	2000-07-27
ZA200103081B (en)	2002-07-12
ID28441A (en)	2001-05-24
BR9914419A (en)	2001-06-26
NO20011403D0 (en)	2001-03-20
IL142588A0 (en)	2002-03-10
HRP20010262A2 (en)	2002-06-30
PL348107A1 (en)	2002-05-06
KR20010072878A (en)	2001-07-31
WO2000023057A2 (en)	2000-04-27
CN1367697A (en)	2002-09-04
TR200101082T2 (en)	2001-09-21
EE200100136A (en)	2002-06-17
HK1039745A1 (en)	2002-05-10
AU6472799A (en)	2000-05-08
NO20011403L (en)	2001-03-20
JP2002527469A (en)	2002-08-27
SK4592001A3 (en)	2001-12-03
EP1121131A2 (en)	2001-08-08
CA2345767A1 (en)	2000-04-27
HUP0103781A2 (en)	2002-03-28
BG105302A (en)	2001-11-30

Similar Documents

Publication	Publication Date	Title
HUP0103781A3 (en)	2003-09-29	Pharmaceutical compositions comprising atypical antiphsychotic agent in combination with acetylcholinesterase inhibitor for improving cognition
IL206621A0 (en)	2010-12-30	Caspase inhibitors and pharmaceutical compositions containing the same
HUP0104768A3 (en)	2002-05-28	4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
HUP0101810A3 (en)	2002-05-28	Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them
IL151372A0 (en)	2003-04-10	Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
IL150224A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
IL144977A0 (en)	2002-06-30	Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0203971A3 (en)	2005-01-28	Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use
HUP0105113A3 (en)	2004-11-29	Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
HUP0203378A3 (en)	2004-07-28	Pharmaceutical compounds and pharmaceutical compositions containing them
PL362177A1 (en)	2004-10-18	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0103188A2 (en)	2001-12-28	Compounds and compositions for delivering active agents
HUP0203728A3 (en)	2003-12-29	Aerosol composition comprising formoterol
IL152315A0 (en)	2003-05-29	Soluble ctla4 mutant molecules and pharmaceutical compositions containing the same
IL152718A0 (en)	2003-06-24	Piperidine derivatives and pharmaceutical compositions containing the same
IL138899A0 (en)	2001-11-25	Amidene derivatives and pharmaceutical compositions containing the same
HUP0203965A3 (en)	2003-07-28	Indazole compounds and pharmaceutical compositions containing them
IL156558A0 (en)	2004-01-04	Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0203939A3 (en)	2004-12-28	Pharmaceutical compounds and compositions containing them and their use
IL140862A (en)	2005-05-17	Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL149580A0 (en)	2002-11-10	Analgesic compositions containing buprenorphine
IL143920A0 (en)	2002-04-21	3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL152846A0 (en)	2003-06-24	Pyridazinone derivatives and pharmaceutical compositions containing the same
IL138572A0 (en)	2001-10-31	Benzoate derivatives and pharmaceutical compositions containing the same